Jae-Chul Kim
Chairman at DONGWON ENTERPRISE CO.,LTD
Net worth: 201 M $ as of 2024-06-29
Profile
Jae-Chul Kim is currently the Chairman at Dongwon Enterprise Co., Ltd.
He previously held the position of Chairman at DONGWON INDUSTRIES Co., Ltd.
and was a Research Fellow at Pacific Pharmaceutical Co., Ltd.
Kim completed his undergraduate degree at Pukyong National University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
DONGWON INDUSTRIES CO., LTD
21.49% | 2024-05-09 | 7,742,020 ( 21.49% ) | 201 M $ | 2024-06-29 |
Jae-Chul Kim active positions
Companies | Position | Start |
---|---|---|
DONGWON ENTERPRISE CO.,LTD | Chairman | 2004-11-09 |
Former positions of Jae-Chul Kim
Companies | Position | End |
---|---|---|
DONGWON INDUSTRIES CO., LTD. | Chairman | - |
PACIFICPHARMA CORP | Corporate Officer/Principal | - |
Training of Jae-Chul Kim
Pukyong National University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
DONGWON INDUSTRIES CO., LTD. | Transportation |
Private companies | 2 |
---|---|
Dongwon Enterprise Co., Ltd.
Dongwon Enterprise Co., Ltd. Air Freight/CouriersTransportation Dongwon Enterprise Co., Ltd. is a holding company, which provides business and investment management services for the Dongwon Group. It offers brand and portfolio management and business expansion support. The company was founded on April 16, 2001 and is headquartered in Seoul, South Korea. | Transportation |
Pacific Pharmaceutical Co., Ltd.
Pacific Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Pacific Pharmaceutical Co. Ltd. is manufacturing of medicinal and pharmaceutical products. Its products include ethical medicine such as plasters used in damaged bones, skins, sinews and fleshes, gastrological medicines, athletes foot remedies, antiphlogistics, liver remedies, antibiotics and antacids, anti-inflammatory analgesics and diabetes and circulatory remedies. It was founded on December 16, 1982 and is headquartered in Seoul, South Korea. | Health Technology |
- Stock Market
- Insiders
- Jae-Chul Kim